The US peripheral artery revascularization market is growing due to the increasing prevalence of peripheral artery disease, diabetes, and other cardiovascular risk factors. Rising adoption of minimally invasive endovascular procedures, including angioplasty, atherectomy, and stent-based interventions, is supporting market expansion. Advances in revascularization technologies and growing...